India has been offered 7.5 million doses of Moderna’s COVID-19 vaccine through the COVAX global vaccine sharing programme. However, there is no clarity over when these will be available in the country.
Last month, the Drug Controller General of India (DCGI) had granted permission to India pharma company Cipla to import Moderna’s Covid-19 vaccine for restricted emergency usage.
Despite being given the permission, the delay is because the consensus on indemnity clause is yet to be reached.
NITI Aayog member (Health) Dr V K Paul had recently told media persons that the government is working actively with Moderna to facilitate the availability in the country. The government sources said that discussions are happening between the company and the government over the specifics of granting permission and no final agreement has been reached as of now.
If Moderna comes to India, it would be the fourth Covid-19 available in the country apart from Covishield, Covaxin and Sputnik.
India has administered 41.18 crore vaccine doses till date.